e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cell biology of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Application of omics technologies to the identification of biomarkers for COPD
I. Kilty, R. Walsh, J. Bandow, R. Hidi, G. Johnston, P. Phillips, S. Ward, L. Nagy (Sandwich, United Kingdom; Debrecen, Hungary)
Source:
Annual Congress 2007 - Cell biology of asthma and COPD
Session:
Cell biology of asthma and COPD
Session type:
Oral Presentation
Number:
1309
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Kilty, R. Walsh, J. Bandow, R. Hidi, G. Johnston, P. Phillips, S. Ward, L. Nagy (Sandwich, United Kingdom; Debrecen, Hungary). Application of omics technologies to the identification of biomarkers for COPD. Eur Respir J 2007; 30: Suppl. 51, 1309
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012
Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009
Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
The audit-intervention-reaudit cycle can improve diagnostic standards for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011
Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011
Access and use of communication technologies in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011
Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The future of disease monitoring and management: the homework for clinical researchers
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Source: Guideline 1995
Year: 1995
Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept